FDA Inspection 1304730 — NYU Langone Reproductive Specialists of New York
The FDA completed an inspection of NYU Langone Reproductive Specialists of New York on February 27, 2026 in Mineola, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 27, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Mineola, NY (United States)